MALAT1 and hepatocellular carcinoma: Moreover, upregulation of MALAT1 in HCC was reported to be associated with chemoresistance to multiple agents, including 5-fluorouracil, mitomycin C, and Adriamycin via a hypoxia-inducible factor (HIF)-1α-MALAT1-microRNA (mir)-216b pathway [17].